標題: When we can do it with MDMA and therapeutic support [打印本頁] 作者: jinathjemi88888 時間: 2024-3-16 17:43 標題: When we can do it with MDMA and therapeutic support
So at the age of 20, Doblin created the Multidisciplinary Association for Psychedelic Studies, or MAPS. Under his direction, MAPS has raised $70 million for research into the potential of psychedelics to treat a variety of mental illnesses, including depression, anxiety and PTSD. Investors and doctors are increasingly embracing psychedelics to treat conditions such as depression, and a ketamine-based drug was recently approved for the disorder. There may be more to come, thanks to MAPS.
Jennifer Doudna, a professor at the University of California, Berkeley, helped invent the gene-editing tool Crispr Jennifer Doudna, a professor at the University of California at Berkeley, helped invent blockbuster gene-editing tool Crispr Alexander Heinl; Picture alliance via Getty Images Jennifer Doudna learned via email that a scientist in China had used the gene-editing tool SW Business Directory she had helped invent to edit the DNA of a pair of twin girls . "It was pretty devastating," the 55-year-old University of California geneticist tells Business Insider. "He was quite shocked." Doudna had unearthed the tool, called Crispr, in early experiments with bacteria in 2012. Since then, he has envisioned dozens of applications for it, from treating diseases like sickle cell disease to creating tastier products and even growing crops . drought resistant .
For years, she has also feared that someone could secretly use it to interfere with human DNA. And that's exactly what happened when researcher He Jiankui edited the twins' DNA. To address this, Doudna says we need to provide anyone thinking about modifying the genes of human embryos with "a very concrete guide to criteria recognized by international forums." Doudna is still hopeful about Crispr's applications in other areas, such as treating diseases and creating superior foods . “I think in the next five years the most profound changes we will see in people's daily lives thanks to Crispr will be in the agricultural sector,” she says. Rushika Fernandopulle, CEO of Iora Health, is inventing a whole new way to go to the doctor Rushika Fernandopulle, the CEO of Iora Health, is inventing an entirely new way to go to the doctor Tony Luong for Business Insider Hace 15 años, Rushika Fernandopulle tuvo una idea radical.
